VRTX vs GILD: Which Stock is Better?
Side-by-side comparison of Vertex Pharmaceuticals Inc and Gilead Sciences Inc in 2026
VRTX
Vertex Pharmaceuticals Inc
$496.83
GILD
Gilead Sciences Inc
$148.95
Key Metrics Comparison
| Metric | VRTX | GILD | Winner |
|---|---|---|---|
| Market Cap | $121.95B | $178.37B | GILD |
| P/E Ratio | 31.34 | 21.17 | GILD |
| EPS (TTM) | $15.32 | $6.79 | VRTX |
| Revenue Growth | 0.1% | 0.0% | VRTX |
| Gross Margin | 53.7% | 78.8% | GILD |
Analyze VRTX
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is VRTX or GILD a better investment?
Comparing VRTX and GILD: Vertex Pharmaceuticals Inc has a market cap of $121.95B while Gilead Sciences Inc has $178.37B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between VRTX and GILD?
VRTX (Vertex Pharmaceuticals Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: VRTX or GILD?
Based on P/E ratios, GILD trades at a lower multiple (21.2x vs 31.3x).
Which is growing faster: VRTX or GILD?
VRTX has higher revenue growth at 0.1% vs 0.0% for GILD.
Which company is more profitable: VRTX or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to 53.7% for VRTX.
Which is the larger company: VRTX or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $178.37B compared to $121.95B for VRTX.
Should I buy VRTX or GILD in 2026?
Both VRTX and GILD have investment merit. VRTX trades at $496.83 while GILD trades at $148.95. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between VRTX and GILD stock?
Key differences: Market Cap ($121.95B vs $178.37B), P/E Ratio (31.3x vs 21.2x), Revenue Growth (0.1% vs 0.0%), Gross Margin (53.7% vs 78.8%).